Loading…

Outcomes of robotic‐assisted versus open radical cystectomy in a large‐scale, contemporary cohort of bladder cancer patients

Background and Objectives To test for differences in perioperative outcomes and total hospital costs (THC) in nonmetastatic bladder cancer patients undergoing open (ORC) versus robotic‐assisted radical cystectomy (RARC). Methods We relied on the National Inpatient Sample database (2016–2019). Statis...

Full description

Saved in:
Bibliographic Details
Published in:Journal of surgical oncology 2022-09, Vol.126 (4), p.830-837
Main Authors: Hoeh, Benedikt, Flammia, Rocco S., Hohenhorst, Lukas, Sorce, Gabriele, Chierigo, Francesco, Panunzio, Andrea, Tian, Zhe, Saad, Fred, Gallucci, Michele, Briganti, Alberto, Terrone, Carlo, Shariat, Shahrokh F., Graefen, Markus, Tilki, Derya, Antonelli, Alessandro, Kluth, Luis A., Becker, Andreas, Chun, Felix K. H., Karakiewicz, Pierre I.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3883-20b9eef537d6679bf9b52e8b0c2e72d7c65379144cc1f6f3e28c4daffe6838bf3
cites cdi_FETCH-LOGICAL-c3883-20b9eef537d6679bf9b52e8b0c2e72d7c65379144cc1f6f3e28c4daffe6838bf3
container_end_page 837
container_issue 4
container_start_page 830
container_title Journal of surgical oncology
container_volume 126
creator Hoeh, Benedikt
Flammia, Rocco S.
Hohenhorst, Lukas
Sorce, Gabriele
Chierigo, Francesco
Panunzio, Andrea
Tian, Zhe
Saad, Fred
Gallucci, Michele
Briganti, Alberto
Terrone, Carlo
Shariat, Shahrokh F.
Graefen, Markus
Tilki, Derya
Antonelli, Alessandro
Kluth, Luis A.
Becker, Andreas
Chun, Felix K. H.
Karakiewicz, Pierre I.
description Background and Objectives To test for differences in perioperative outcomes and total hospital costs (THC) in nonmetastatic bladder cancer patients undergoing open (ORC) versus robotic‐assisted radical cystectomy (RARC). Methods We relied on the National Inpatient Sample database (2016–2019). Statistics consisted of trend analyses, multivariable logistic, Poisson, and linear regression models. Results Of 5280 patients, 1876 (36%) versus 3200 (60%) underwent RARC versus ORC. RARC increased from 32% to 41% (estimated annual percentage change [EAPC]: + 8.6%; p = 0.02). Rates of transfusion (8% vs. 16%), intraoperative (2% vs. 3%), wound (6% vs. 10%), and pulmonary (6% vs. 10%) complications were lower in RARC patients (all p 
doi_str_mv 10.1002/jso.26973
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2673594544</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2700311439</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3883-20b9eef537d6679bf9b52e8b0c2e72d7c65379144cc1f6f3e28c4daffe6838bf3</originalsourceid><addsrcrecordid>eNp1kc1O3DAURi1EVQbaBS-ALLEpEgH_xYmXaAQtCGkWbdeW41xDRkkcbIdqdjwCz9gnwXSgi0pdXV19x0fX-hA6pOSMEsLO19GfMakqvoMWlChZKKLqXbTIGStEpcge2o9xTQhRSoqPaI-XUlIu6QI9reZk_QARe4eDb3zq7O-nZxNjFxO0-BFCnHM4wYiDaTtremw3ObLJDxvcjdjg3oQ7yI9iDuEUWz8mGCYfTNjk5d6H9CpvetO2ELA1o81jMqmDMcVP6IMzfYTPb_MA_by6_LH8Vtyuvl4vL24Ly-uaF4w0CsCVvGqlrFTjVFMyqBtiGVSsrazMkaJCWEuddBxYbUVrnANZ87px_AB92Xqn4B9miEkPXbTQ92YEP0fNZMVLJUohMnr8D7r2cxjzdZpVhHBKBVeZOtlSNvgYAzg9hW7If9aU6NdadK5F_6kls0dvxrkZoP1LvveQgfMt8KvrYfN_k775vtoqXwD5uJsm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2700311439</pqid></control><display><type>article</type><title>Outcomes of robotic‐assisted versus open radical cystectomy in a large‐scale, contemporary cohort of bladder cancer patients</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Hoeh, Benedikt ; Flammia, Rocco S. ; Hohenhorst, Lukas ; Sorce, Gabriele ; Chierigo, Francesco ; Panunzio, Andrea ; Tian, Zhe ; Saad, Fred ; Gallucci, Michele ; Briganti, Alberto ; Terrone, Carlo ; Shariat, Shahrokh F. ; Graefen, Markus ; Tilki, Derya ; Antonelli, Alessandro ; Kluth, Luis A. ; Becker, Andreas ; Chun, Felix K. H. ; Karakiewicz, Pierre I.</creator><creatorcontrib>Hoeh, Benedikt ; Flammia, Rocco S. ; Hohenhorst, Lukas ; Sorce, Gabriele ; Chierigo, Francesco ; Panunzio, Andrea ; Tian, Zhe ; Saad, Fred ; Gallucci, Michele ; Briganti, Alberto ; Terrone, Carlo ; Shariat, Shahrokh F. ; Graefen, Markus ; Tilki, Derya ; Antonelli, Alessandro ; Kluth, Luis A. ; Becker, Andreas ; Chun, Felix K. H. ; Karakiewicz, Pierre I.</creatorcontrib><description><![CDATA[Background and Objectives To test for differences in perioperative outcomes and total hospital costs (THC) in nonmetastatic bladder cancer patients undergoing open (ORC) versus robotic‐assisted radical cystectomy (RARC). Methods We relied on the National Inpatient Sample database (2016–2019). Statistics consisted of trend analyses, multivariable logistic, Poisson, and linear regression models. Results Of 5280 patients, 1876 (36%) versus 3200 (60%) underwent RARC versus ORC. RARC increased from 32% to 41% (estimated annual percentage change [EAPC]: + 8.6%; p = 0.02). Rates of transfusion (8% vs. 16%), intraoperative (2% vs. 3%), wound (6% vs. 10%), and pulmonary (6% vs. 10%) complications were lower in RARC patients (all p < 0.05). Moreover, median length of stay (LOS) was shorter in RARC (6 vs. 7days; p < 0.001). Conversely, median THC (31,486 vs. 27,162$; p < 0.001) were higher in RARC. Multivariable logistic regression‐derived odds ratios addressing transfusion (0.49), intraoperative (0.53), wound (0.68), and pulmonary (0.71) complications favored RARC (all p < 0.01). In multivariable Poisson and linear regression models, RARC was associated with shorter LOS (Rate ratio:0.86; p < 0.001), yet higher THC (Coef.:5,859$; p < 0.001). RARC in‐hospital mortality was lower (1% vs. 2%; p = 0.04). Conclusions RARC complications, LOS, and mortality appear more favorable than ORC, but result in higher THC. The favorable RARC profile contributes to its increasing popularity throughout the United States.]]></description><identifier>ISSN: 0022-4790</identifier><identifier>EISSN: 1096-9098</identifier><identifier>DOI: 10.1002/jso.26973</identifier><identifier>PMID: 35661361</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Bladder cancer ; complication ; Cystectomy - adverse effects ; Hospital costs ; Humans ; open ; outcomes ; Postoperative Complications - etiology ; radical cystectomy ; Regression analysis ; Robotic Surgical Procedures ; robotic‐assisted ; Treatment Outcome ; Urinary Bladder ; Urinary Bladder Neoplasms</subject><ispartof>Journal of surgical oncology, 2022-09, Vol.126 (4), p.830-837</ispartof><rights>2022 The Authors. published by Wiley Periodicals LLC.</rights><rights>2022 The Authors. Journal of Surgical Oncology published by Wiley Periodicals LLC.</rights><rights>2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3883-20b9eef537d6679bf9b52e8b0c2e72d7c65379144cc1f6f3e28c4daffe6838bf3</citedby><cites>FETCH-LOGICAL-c3883-20b9eef537d6679bf9b52e8b0c2e72d7c65379144cc1f6f3e28c4daffe6838bf3</cites><orcidid>0000-0002-3129-0544 ; 0000-0002-4238-6584</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35661361$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hoeh, Benedikt</creatorcontrib><creatorcontrib>Flammia, Rocco S.</creatorcontrib><creatorcontrib>Hohenhorst, Lukas</creatorcontrib><creatorcontrib>Sorce, Gabriele</creatorcontrib><creatorcontrib>Chierigo, Francesco</creatorcontrib><creatorcontrib>Panunzio, Andrea</creatorcontrib><creatorcontrib>Tian, Zhe</creatorcontrib><creatorcontrib>Saad, Fred</creatorcontrib><creatorcontrib>Gallucci, Michele</creatorcontrib><creatorcontrib>Briganti, Alberto</creatorcontrib><creatorcontrib>Terrone, Carlo</creatorcontrib><creatorcontrib>Shariat, Shahrokh F.</creatorcontrib><creatorcontrib>Graefen, Markus</creatorcontrib><creatorcontrib>Tilki, Derya</creatorcontrib><creatorcontrib>Antonelli, Alessandro</creatorcontrib><creatorcontrib>Kluth, Luis A.</creatorcontrib><creatorcontrib>Becker, Andreas</creatorcontrib><creatorcontrib>Chun, Felix K. H.</creatorcontrib><creatorcontrib>Karakiewicz, Pierre I.</creatorcontrib><title>Outcomes of robotic‐assisted versus open radical cystectomy in a large‐scale, contemporary cohort of bladder cancer patients</title><title>Journal of surgical oncology</title><addtitle>J Surg Oncol</addtitle><description><![CDATA[Background and Objectives To test for differences in perioperative outcomes and total hospital costs (THC) in nonmetastatic bladder cancer patients undergoing open (ORC) versus robotic‐assisted radical cystectomy (RARC). Methods We relied on the National Inpatient Sample database (2016–2019). Statistics consisted of trend analyses, multivariable logistic, Poisson, and linear regression models. Results Of 5280 patients, 1876 (36%) versus 3200 (60%) underwent RARC versus ORC. RARC increased from 32% to 41% (estimated annual percentage change [EAPC]: + 8.6%; p = 0.02). Rates of transfusion (8% vs. 16%), intraoperative (2% vs. 3%), wound (6% vs. 10%), and pulmonary (6% vs. 10%) complications were lower in RARC patients (all p < 0.05). Moreover, median length of stay (LOS) was shorter in RARC (6 vs. 7days; p < 0.001). Conversely, median THC (31,486 vs. 27,162$; p < 0.001) were higher in RARC. Multivariable logistic regression‐derived odds ratios addressing transfusion (0.49), intraoperative (0.53), wound (0.68), and pulmonary (0.71) complications favored RARC (all p < 0.01). In multivariable Poisson and linear regression models, RARC was associated with shorter LOS (Rate ratio:0.86; p < 0.001), yet higher THC (Coef.:5,859$; p < 0.001). RARC in‐hospital mortality was lower (1% vs. 2%; p = 0.04). Conclusions RARC complications, LOS, and mortality appear more favorable than ORC, but result in higher THC. The favorable RARC profile contributes to its increasing popularity throughout the United States.]]></description><subject>Bladder cancer</subject><subject>complication</subject><subject>Cystectomy - adverse effects</subject><subject>Hospital costs</subject><subject>Humans</subject><subject>open</subject><subject>outcomes</subject><subject>Postoperative Complications - etiology</subject><subject>radical cystectomy</subject><subject>Regression analysis</subject><subject>Robotic Surgical Procedures</subject><subject>robotic‐assisted</subject><subject>Treatment Outcome</subject><subject>Urinary Bladder</subject><subject>Urinary Bladder Neoplasms</subject><issn>0022-4790</issn><issn>1096-9098</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp1kc1O3DAURi1EVQbaBS-ALLEpEgH_xYmXaAQtCGkWbdeW41xDRkkcbIdqdjwCz9gnwXSgi0pdXV19x0fX-hA6pOSMEsLO19GfMakqvoMWlChZKKLqXbTIGStEpcge2o9xTQhRSoqPaI-XUlIu6QI9reZk_QARe4eDb3zq7O-nZxNjFxO0-BFCnHM4wYiDaTtremw3ObLJDxvcjdjg3oQ7yI9iDuEUWz8mGCYfTNjk5d6H9CpvetO2ELA1o81jMqmDMcVP6IMzfYTPb_MA_by6_LH8Vtyuvl4vL24Ly-uaF4w0CsCVvGqlrFTjVFMyqBtiGVSsrazMkaJCWEuddBxYbUVrnANZ87px_AB92Xqn4B9miEkPXbTQ92YEP0fNZMVLJUohMnr8D7r2cxjzdZpVhHBKBVeZOtlSNvgYAzg9hW7If9aU6NdadK5F_6kls0dvxrkZoP1LvveQgfMt8KvrYfN_k775vtoqXwD5uJsm</recordid><startdate>20220901</startdate><enddate>20220901</enddate><creator>Hoeh, Benedikt</creator><creator>Flammia, Rocco S.</creator><creator>Hohenhorst, Lukas</creator><creator>Sorce, Gabriele</creator><creator>Chierigo, Francesco</creator><creator>Panunzio, Andrea</creator><creator>Tian, Zhe</creator><creator>Saad, Fred</creator><creator>Gallucci, Michele</creator><creator>Briganti, Alberto</creator><creator>Terrone, Carlo</creator><creator>Shariat, Shahrokh F.</creator><creator>Graefen, Markus</creator><creator>Tilki, Derya</creator><creator>Antonelli, Alessandro</creator><creator>Kluth, Luis A.</creator><creator>Becker, Andreas</creator><creator>Chun, Felix K. H.</creator><creator>Karakiewicz, Pierre I.</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3129-0544</orcidid><orcidid>https://orcid.org/0000-0002-4238-6584</orcidid></search><sort><creationdate>20220901</creationdate><title>Outcomes of robotic‐assisted versus open radical cystectomy in a large‐scale, contemporary cohort of bladder cancer patients</title><author>Hoeh, Benedikt ; Flammia, Rocco S. ; Hohenhorst, Lukas ; Sorce, Gabriele ; Chierigo, Francesco ; Panunzio, Andrea ; Tian, Zhe ; Saad, Fred ; Gallucci, Michele ; Briganti, Alberto ; Terrone, Carlo ; Shariat, Shahrokh F. ; Graefen, Markus ; Tilki, Derya ; Antonelli, Alessandro ; Kluth, Luis A. ; Becker, Andreas ; Chun, Felix K. H. ; Karakiewicz, Pierre I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3883-20b9eef537d6679bf9b52e8b0c2e72d7c65379144cc1f6f3e28c4daffe6838bf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Bladder cancer</topic><topic>complication</topic><topic>Cystectomy - adverse effects</topic><topic>Hospital costs</topic><topic>Humans</topic><topic>open</topic><topic>outcomes</topic><topic>Postoperative Complications - etiology</topic><topic>radical cystectomy</topic><topic>Regression analysis</topic><topic>Robotic Surgical Procedures</topic><topic>robotic‐assisted</topic><topic>Treatment Outcome</topic><topic>Urinary Bladder</topic><topic>Urinary Bladder Neoplasms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hoeh, Benedikt</creatorcontrib><creatorcontrib>Flammia, Rocco S.</creatorcontrib><creatorcontrib>Hohenhorst, Lukas</creatorcontrib><creatorcontrib>Sorce, Gabriele</creatorcontrib><creatorcontrib>Chierigo, Francesco</creatorcontrib><creatorcontrib>Panunzio, Andrea</creatorcontrib><creatorcontrib>Tian, Zhe</creatorcontrib><creatorcontrib>Saad, Fred</creatorcontrib><creatorcontrib>Gallucci, Michele</creatorcontrib><creatorcontrib>Briganti, Alberto</creatorcontrib><creatorcontrib>Terrone, Carlo</creatorcontrib><creatorcontrib>Shariat, Shahrokh F.</creatorcontrib><creatorcontrib>Graefen, Markus</creatorcontrib><creatorcontrib>Tilki, Derya</creatorcontrib><creatorcontrib>Antonelli, Alessandro</creatorcontrib><creatorcontrib>Kluth, Luis A.</creatorcontrib><creatorcontrib>Becker, Andreas</creatorcontrib><creatorcontrib>Chun, Felix K. H.</creatorcontrib><creatorcontrib>Karakiewicz, Pierre I.</creatorcontrib><collection>Wiley-Blackwell Open Access Collection</collection><collection>Wiley-Blackwell Backfiles (Open access)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hoeh, Benedikt</au><au>Flammia, Rocco S.</au><au>Hohenhorst, Lukas</au><au>Sorce, Gabriele</au><au>Chierigo, Francesco</au><au>Panunzio, Andrea</au><au>Tian, Zhe</au><au>Saad, Fred</au><au>Gallucci, Michele</au><au>Briganti, Alberto</au><au>Terrone, Carlo</au><au>Shariat, Shahrokh F.</au><au>Graefen, Markus</au><au>Tilki, Derya</au><au>Antonelli, Alessandro</au><au>Kluth, Luis A.</au><au>Becker, Andreas</au><au>Chun, Felix K. H.</au><au>Karakiewicz, Pierre I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes of robotic‐assisted versus open radical cystectomy in a large‐scale, contemporary cohort of bladder cancer patients</atitle><jtitle>Journal of surgical oncology</jtitle><addtitle>J Surg Oncol</addtitle><date>2022-09-01</date><risdate>2022</risdate><volume>126</volume><issue>4</issue><spage>830</spage><epage>837</epage><pages>830-837</pages><issn>0022-4790</issn><eissn>1096-9098</eissn><abstract><![CDATA[Background and Objectives To test for differences in perioperative outcomes and total hospital costs (THC) in nonmetastatic bladder cancer patients undergoing open (ORC) versus robotic‐assisted radical cystectomy (RARC). Methods We relied on the National Inpatient Sample database (2016–2019). Statistics consisted of trend analyses, multivariable logistic, Poisson, and linear regression models. Results Of 5280 patients, 1876 (36%) versus 3200 (60%) underwent RARC versus ORC. RARC increased from 32% to 41% (estimated annual percentage change [EAPC]: + 8.6%; p = 0.02). Rates of transfusion (8% vs. 16%), intraoperative (2% vs. 3%), wound (6% vs. 10%), and pulmonary (6% vs. 10%) complications were lower in RARC patients (all p < 0.05). Moreover, median length of stay (LOS) was shorter in RARC (6 vs. 7days; p < 0.001). Conversely, median THC (31,486 vs. 27,162$; p < 0.001) were higher in RARC. Multivariable logistic regression‐derived odds ratios addressing transfusion (0.49), intraoperative (0.53), wound (0.68), and pulmonary (0.71) complications favored RARC (all p < 0.01). In multivariable Poisson and linear regression models, RARC was associated with shorter LOS (Rate ratio:0.86; p < 0.001), yet higher THC (Coef.:5,859$; p < 0.001). RARC in‐hospital mortality was lower (1% vs. 2%; p = 0.04). Conclusions RARC complications, LOS, and mortality appear more favorable than ORC, but result in higher THC. The favorable RARC profile contributes to its increasing popularity throughout the United States.]]></abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>35661361</pmid><doi>10.1002/jso.26973</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-3129-0544</orcidid><orcidid>https://orcid.org/0000-0002-4238-6584</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-4790
ispartof Journal of surgical oncology, 2022-09, Vol.126 (4), p.830-837
issn 0022-4790
1096-9098
language eng
recordid cdi_proquest_miscellaneous_2673594544
source Wiley-Blackwell Read & Publish Collection
subjects Bladder cancer
complication
Cystectomy - adverse effects
Hospital costs
Humans
open
outcomes
Postoperative Complications - etiology
radical cystectomy
Regression analysis
Robotic Surgical Procedures
robotic‐assisted
Treatment Outcome
Urinary Bladder
Urinary Bladder Neoplasms
title Outcomes of robotic‐assisted versus open radical cystectomy in a large‐scale, contemporary cohort of bladder cancer patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T12%3A28%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20of%20robotic%E2%80%90assisted%20versus%20open%20radical%20cystectomy%20in%20a%20large%E2%80%90scale,%20contemporary%20cohort%20of%20bladder%20cancer%20patients&rft.jtitle=Journal%20of%20surgical%20oncology&rft.au=Hoeh,%20Benedikt&rft.date=2022-09-01&rft.volume=126&rft.issue=4&rft.spage=830&rft.epage=837&rft.pages=830-837&rft.issn=0022-4790&rft.eissn=1096-9098&rft_id=info:doi/10.1002/jso.26973&rft_dat=%3Cproquest_cross%3E2700311439%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3883-20b9eef537d6679bf9b52e8b0c2e72d7c65379144cc1f6f3e28c4daffe6838bf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2700311439&rft_id=info:pmid/35661361&rfr_iscdi=true